Thrombocytopenia and platelet microvesicle formation caused by Legionella pneumophila Infection

Thrombosis Research

Volumn 96, Issue 5, 1999, Pages 391-397

  Larsson, Anders ^a   Nilsson, Bo ^b   Eriksson, Mats ^c  

^a Clinical Chemistry   (Sweden)

^b Dept Clin Immunol and Transfus Medicine ^*  (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood platelets; Complement activation; Legionella pneumophila; Sepsis; Thrombocytopenia

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B RECEPTOR; HEPARIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CAVERNOUS SINUS THROMBOSIS; COMPLEMENT ACTIVATION; FLOW CYTOMETRY; HUMAN; LEGIONELLA PNEUMOPHILA; MALE; PRIORITY JOURNAL; SEPSIS; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA;

EID: 0032764002     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00119-X     Document Type: Article

References (23)

1. Breiman R.F., Butler J.C. Legionnaire's disease. Clinical, epidemiological, and public health perspectives Semin Respir Infect. 13:1998;84-89.
2. Payne N.R., Horwitz M.A. Phagocytosis of L. pneumophila is mediated by human monocyte complement receptors. J Exp Med. 166:1987;1377-1389.
3. Mintz C.S., Schultz D.R., Arnold P.I., Johnson W. L. pneumophila lipopolysaccharide activates the classical complement pathway. Infect Immun. 60:1992;2769-2776.
4. Mintz C.S., Arnold P.I., Johnson W., Schultz D.R. Antibody-independent binding of complement component C1q by L. pneumophila. Infect Immun. 63:1995;4939-4943.
5. Bellinger-Kawahara C., Horwitz M.A. Complement component C3 fixes selectively to the major outer membrane protein (MOMP) of L. pneumophila and mediates phagocytosis of liposome-MOMP complexes by human monocytes. J Exp Med. 172:1990;1201-1210.
6. Lindahl T., Larsson A. C1q binding to platelets induced by monoclonal antibodies and immune complexes - A flow cytometric analysis. Platelets. 4:1993;73-77.
7. Kekomaki R., Kauppinen H.L., Penttinen K., Myllylä G. Interaction of immune complexes and platelets in rabbits immunized with hapten-carrier conjugates. Acta Pathol Microbiol Scand Sect C. 86:1977;207-214.
8. Penttinen K., Makela O., Vaheri A. Soluble antigen-antibody complexes and platelet aggregation. Acta Pathol Microbiol Scand. 77:1969;309-317.
9. Sims P.J., Faioni E.M., Wiedmer T., Shattil S.J. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombin activity. J Biol Chem. 263:1988;18205-18212.
10. Fijnheer R, Pietersz RNI, Huijgens PC, de Korte D, Reesink HW, von dem Borne AEG, Roos D. Survival of activated platelets after transfusion. Doctoral thesis, University of Amsterdam, Amsterdam, The Netherlands. 1991.
11. Abrams C.S., Ellison N., Budzynski A.Z., Shattil S.J. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood. 75:1990;128-138.
12. Lindahl T.L., Festin R., Larsson A. Studies of fibrinogen binding to platelets by flow cytometry. An improved method for detection of platelet activation Thrombosis and Haemostasis. 68:1992;221-225.
13. Nilsson U.R., Nilsson B. Simplified assays of hemolytic activity of the classical and alternative pathways. J Immunol Methods. 72:1984;49-59.
14. Horwitz M.S. Phagocytosis of the Legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism. Engulfment within a pseudopod coil Cell. 36:1984;27-33.
15. McGill M., Fugman D.A., Vittorio N., Darrow C. Platelet membrane microvesicles reduced microvascular bleeding times in thrombocytopenic rabbits. J Clin Invest. 109:1987;127-133.
16. Jy W., Horstman L.L., Arce M., Ahn Y.S. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med. 119:1992;334-345.
17. Lee Y.J., Jy W., Horstman L.L., Janania J., Reyes Y., Kelley R.E., Ahn Y.S. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res. 72:1993;295-304.
18. Larsson A., Lundahl T., Eriksson M., Lundkvist K., Lindahl T. Endotoxin induced platelet microvesicle formation measured by flow cytometry. Platelets. 7:1996;153-158.
19. Eriksson M., Nelson D., Nordgren A., Larsson A. Increased platelet microvesicle formation is associated with mortality in a porcine model of endotoxemia. Acta Anaesthesiol Scand. 42:1998;551-557.
20. Howard M.A., Coghlan M., David R., Pfueller S.L. Coagulation activities of plasma microparticles. Thromb Res. 50:1988;145-156.
21. Summergill J.T., Powell L.A., Buster B.L., Miller R.D., Ramirez J.A. Killing of L. pneumophila by nitric oxide in gamma-interferon-activated macrophages. J Leukoc Biol. 52:1992;625-629.
22. Mulligan M.S., Yeh C.G., Rudolph A.R., Ward P. Protective effects of soluble CR1 in complement- and neuthrophil-mediated tissue injury. J Immunol. 148:1992;1479-1485.
23. Nilsson B., Larsson R., Hong J., Elgue G., Ekdahl K.N., Sahu A., Lambris J.D. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood. 92:1998;1661-1667.